Catch up on the latest COVID-19 news in this week’s roundup! Coverage includes the efficacy and safety of sotrovimab as a COVID-19 treatment, recommendations on the management of myocardial sequelae,...
In a recent study, researchers investigated whether women with multiple sclerosis have an increased risk of relapse after pregnancy, and whether this risk is impacted by breastfeeding or disease-modifying...
In a recent study, researchers investigated whether women with multiple sclerosis have an increased risk of relapse after pregnancy, and whether this risk is impacted by breastfeeding or disease-modifying...
After identifying 3 neuroprotective drugs acting on different axonal pathobiologies, the researchers assessed each drug’s efficacy on percentage brain volume change among patients with secondary progressive...
It is unclear why patients with multiple sclerosis have reduced bone mineral density. Authors of a new study investigated the factors that may cause this decrease and found several independent contributors....
For this study, the researchers evaluated whether magnetoencephalography scanning could be a valuable measure of cognitive impairment among patients with multiple sclerosis. Their findings might surprise...
The RADIANCE phase 2 study showed the effectiveness of an investigational MS therapy vs placebo, so authors of the phase 3 SUNBEAM study compared the drug’s efficacy and safety with that of intramuscular...
